Biomedicine & Pharmacotherapy

Biomedicine & Pharmacotherapy

生物医学与药物治疗

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Biomedicine & Pharmacotherapy》是由Elsevier Masson出版社于1982年创办的英文国际期刊(ISSN: 0753-3322,E-ISSN: 1950-6007),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.5432...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比67.58%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在1743篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Biomedicine & Pharmacotherapy审稿周期约为 约2月 约7周。该刊近年被列入国际预警名单,年发文量约1743篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • Multi-Language 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 1743 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
1区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 21 / 189

89.2%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 15 / 354

95.9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 18 / 189

90.74%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 25 / 354

93.08%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:11.9 SJR:1.493 SNIP:1.409
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q1 28 / 313

91%

期刊发文

  • Attenuated WNV-poly(A) exerts a broad-spectrum oncolytic effect by selective virus replication and CD8+T cell-dependent immune response

    Author: Liu, Jing; Hu, Yan-Yan; Zhang, Qiu-Yan; Zhang, Ya-Nan; Li, Na; Zhang, Zhe-Rui; Zhan, Shun-Li; Gao, Lei; Deng, Cheng-Lin; Li, Xiao-Dan; Yuan, Shao-Peng; He, Yuan-Qiao; Ye, Han-Qing; Zhang, Bo

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114094

  • Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease

    Author: Chen, Kuiyu; Wu, Limin; Liu, Qianzhuo; Tan, Fang; Wang, Luyao; Zhao, Dan; Fang, Xinru; Liu, Xiang; Liu, Jiabo; Han, Hui

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114107

  • Arctium lappa (Burdock): Insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine

    Author: Yosri, Nermeen; Alsharif, Sultan M.; Xiao, Jianbo; Musharraf, Syed G.; Zhao, Chao; Saeed, Aamer; Gao, Ruichang; Said, Noha S.; Di Minno, Alessandro; Daglia, Maria; Guo, Zhiming; Khalifa, Shaden A. M.; El-Seedi, Hesham R.

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114104

  • A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma

    Author: Li, Mingfeng; Zhang, Aotong; Qi, Xin; Yu, Rilei; Li, Jing

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114115

  • Sodium tanshinone IIA sulfonate protects against hyperhomocysteine-induced vascular endothelial injury via activation of NNMT/SIRT1-mediated NRF2/HO-1 and AKT/MAPKs signaling in human umbilical vascular endothelial cells

    Author: Zhou, Zhong-Yan; Shi, Wen-Ting; Zhang, Jing; Zhao, Wai-Rong; Xiao, Ying; Zhang, Kai-Yu; Ma, Jie; Tang, Jing-Yi; Wang, Yu

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114137

  • Attenuation of hyperglycemia-associated dyslipidemic, oxidative, cognitive, and inflammatory crises via modulation of neuronal ChEs/NF-kappa B/COX-2/NOx, and hepatorenal functional deficits by the Tridax procumbens extract

    Author: Hogan, Itam Ako; Kuo, Yu-Cheng; Abubakar, Asmau N.; Lawal, Bashir; Agboola, Abdulhakeem R.; Lukman, Halimat Yusuf; Onikanni, Sunday Amos; Olawale, Femi; Fadaka, Adewale Oluwaseun; Ibrahim, Yunusa O.; Babalola, Shukurat B.; Batiha, Gaber El -Saber; Albogami, Sarah M.; Alorabi, Mohammed; De Waard, Michel; Huang, Hsu-Shan

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114114

  • Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K/Akt/NF-kappa B and NLRP3/caspase-1/GSDMD signaling

    Author: Liu, Jiabao; Jia, Shuangshuo; Yang, Yue; Piao, Longhuan; Wang, Ziyuan; Jin, Zhuangzhuang; Bai, Lunhao

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114118

  • Revealment study on the regulation of lipid metabolism by Lingguizhugan Decoction in heart failure treatment based on integrated lipidomics and proteomics

    Author: Wang, Xu; Gao, Yanhua; Zhang, Jia; Zhang, Huaxing; Sun, Shuo; Su, Suwen; Kong, Dezhi; Wang, Qiao

    Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114066